SLC2A1 and non-small cell lung carcinoma: Intriguingly, we also found in this study that GLUT1 was critically involved not only in primary gefitinib resistance associated with the lack of activating EGFR mutations but also in acquired resistance of NSCLC cells (i.e., PC-9-R cells), which were originally sensitive to gefitinib.